Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/20/2013
 
Trade Name:  Dotarem
 
Generic Name or Proper Name (*):  gadoterate meglumine
 
Indications Studied:  Contrast agent for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues to detect and visualize areas with disruption of the blood brain barrier and/or abnormal vascularity
 
Label Changes Summary:  Safety and efficacy have been established in pediatric patients from 2 to 17 yearsSafety and efficacy have not been established in pediatric patients < 2 yearsInformation on clinical trial, dosing, adverse reactionsNew Drug
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Guerbet
 
NNPS:  FALSE'
 
Therapeutic Category:  Medical imaging
 
-
-